Clinical Trials Directory

Trials / Completed

CompletedNCT03273634

The Effect of Proton Pump Inhibition on Palpitations

The Effect of Proton Pump Inhibition on Palpitations With no Apparent Cause. A Double Blinded Randomized Placebo Controlled Trial

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
150 (actual)
Sponsor
Jordan Collaborating Cardiology Group · Academic / Other
Sex
All
Age
16 Years – 99 Years
Healthy volunteers
Not accepted

Summary

Feeling of palpitations with no clear arrhythmia is frequently encountered in clinical practice. The majority of these patients have documented sinus rhythm even while having symptoms. Gastrointestinal association with such symptoms was first described by Ludwig von Roemheld (1871-1938).The investigators thought to investigate the effect of proton pump inhibition in patients with feeling of palpitations but no clear cause.

Detailed description

One hundred and fifty patients with palpitations and no clear cause for their symptoms will be randomized to receive either proton pump inhibitor (PPI) (lanzoprazole 30 mg) or placebo for one month. At base line they will be investigated to rule out arrhythmia by documenting normal heart rate (less than 110 beat per minute) or ECG showing normal sinus rhythm or mild sinus tachycardia (Less than 110 per minute) during symptoms. Obvious causes such as anxiety due to a stressful event or organic causes such anemia or thyroid disorders should be also ruled out. Patient who agree to participate in the study will be asked to sign an informed consent. A baseline questionnaire with symptoms will be filled. They will then be randomized for treatment with either PPI or placebo once at night time. After 10 days of treatment they will be contacted and questioned regarding their symptoms. The two groups will be compared to see if there is any improvement of symptoms with treatment.

Conditions

Interventions

TypeNameDescription
DRUGLansoprazole Pillonce daily at night time
DRUGPlaceboPlacebo

Timeline

Start date
2017-05-20
Primary completion
2018-05-01
Completion
2018-06-01
First posted
2017-09-06
Last updated
2018-08-08

Locations

1 site across 1 country: Jordan

Source: ClinicalTrials.gov record NCT03273634. Inclusion in this directory is not an endorsement.